The stock fell 12% to $6.77 in afternoon trading, the shares are up about 55% in the past 12 months. WW has been pushing into telehealth in a bid to ride the wave of weight-loss drugs. Analysts at DA Davidson said Lilly's telehealth platform, called LillyDirect, will likely have an advantage over rivals while supply of the weight-loss drugs is scarce. The new Lilly service also hit shares of other telehealth companies, including Hims & Hers Health, which traded down about 7%. Write to Will Feuer at Will.Feuer@wsj.com(END) Dow Jones NewswiresJanuary 04, 2024 16:15 ET (21:15 GMT)Copyright (c) 2024 Dow Jones & Company, Inc.

Source: Wall Street Journal January 05, 2024 09:18 UTC